Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published before final editing as: Tob Control. 2021 Feb 1:tobaccocontrol-2020-056269. doi: 10.1136/tobaccocontrol-2020-056269

Table 2:

Proportions of ever-users who vaped/smoked in the past 30 days, past week, and on ≥20 days in the past month, by country, 2017 to 2019

CANADA ENGLAND US
2017 2018 2019 Difference 2019 vs 2018 2017 2018 2019 Difference 2019 vs 2018 2017 2018 2019 Difference 2019 vs 2018
AOR (95% CI); p-value AOR (95% CI); p-value AOR (95% CI); p-value
VAPING (among ever-vapers) n=1182 n=1275 n=1680 n=1348 n=1283 n=1260 n=1283 n=1336 n=1734
Past 30-day vaping 28.8% (340) 36.3% (463) 43.9% (738) 1.36 (1.17–1.59); p<.0001 25.8% (347) 27.3% (351) 34.8% (439) 1.44 (1.19–1.75); p=.0002 35.4% (454) 47.5% (635) 42.5% (736) 0.81 (0.68–0.97); p=.02
Past-week vaping 17.6% (208) 22.7% (290) 30.2% (508) 1.48 (1.24–1.75); p<.0001 13.7% (184) 14.0% (179) 19.2% (241) 1.49 (1.17–1.91); p=.001 20.4% (262) 31.1% (416) 29.0% (503) 0.91 (0.75–1.09); p=.31
Vaping ≥20 days of past 30 6.3% (74) 7.2% (92) 14.0% (236) 2.11 (1.63–2.73); p<.0001 4.4% (59) 5.9% (76) 7.5% (94) 1.33 (0.92–1.94); p=.13 6.9% (89) 11.5% (154) 15.4% (267) 1.42 (1.10–1.85); p=.008
CIGARETTE SMOKING (among ever-smokers) n=1288 n=1193 n=1287 n=1615 n=1554 n=1334 n=1322 n=1306 n=1334
Past 30-day smoking 33.4% (431) 32.1% (383) 29.8% (384) 0.91 (0.77–1.07); p=.24 38.5% (622) 41.5% (645) 38.9% (519) 0.90 (0.76–1.06); p=.19 34.1% (451) 36.0% (470) 23.6% (315) 0.56 (0.46–0.67); p<.0001
Past-week smoking 23.9% (308) 24.4% (291) 22.4% (288) 0.90 (0.76–1.07); p=.23 24.2% (391) 28.6% (444) 26.7% (356) 0.91 (0.76–1.09); p=.29 26.3% (347) 25.7% (336) 17.3% (231) 0.61 (0.50–0.76); p<.0001
Smoking ≥20 days of past 30 13.4% (173) 13.3% (158) 9.2% (118) 0.66 (0.53–0.83); p=.0004 10.7% (173) 14.5% (226) 12.3% (165) 0.83 (0.65–1.05); p=.11 11.4% (151) 11.9% (156) 7.5% (100) 0.61 (0.46–0.80); p=.0004

Data are weighted %(n) or adjusted odds ratios (AOR) with 95% confidence intervals (CI) and associated p-values, adjusted for sex, age group, and race/ethnicity.